GiftChill, Largest E-Gift Cards Platform, Confirms Kishu Inu as Payment

A few days after announcing that it would add Kishu Inu as a payment method, the retailer finally approved it. Gift Chill has done this to keep up with its promise of filling the void in gift card purchases using cryptocurrency.

kishu inu to be used on giftchill

kishu inu to be used on giftchill

QUEBEC CITY, Dec. 11, 2021 (GLOBE NEWSWIRE) — The use of crypto on the platform gives the retailer a unique selling advantage over other online gift card hubs. Kishu is currently available on over 20 exchanges. Although it’s still a relatively new cryptocurrency, it’s on a path to becoming a world leader.

Why Use Kishu Inu for Payment on GiftChill?

GiftChill aims at providing a unique way for shoppers to use cryptocurrency in exchange for gift cards. Their tech-savvy customers can always stay ahead of the curve by using the perks cryptocurrency provides.

Speed and security are some benefits users enjoy in purchasing gift cards. They don’t have to wait for weeks on end for delivery as it happens on competitive sites.

The cards are also verified and guaranteed. This protection is crucial to the security of customer information.

By confirming the use of Kishu Inu, GiftChill has only demonstrated its commitment to crypto as a payment method. The new token offers better rates and reduces overhead costs, as it allows customers to use PayPal and other credit card sites. The platform offers various gift cards to choose from, and the inventory is updated daily.

Investors can enjoy further enrichment by utilizing their currency on various other platforms through GiftChill. They can trade one cryptocurrency for other acceptable ones on Google Play, Amazon, Adidas, Steam, Walmart and more.

Shoppers then receive their gift cards through completely validated email. The email also includes other information the shopper may require, like expiration dates, pins, and company disclosures. Shoppers should feel happy to finally use Kishu Inu to shop for their favorite gift cards. More information is available on Gift Chill’s website and they can be reached on Support@giftchill.co.uk.

Related Images

Image 1: kishu inu to be used on giftchill

kishu inu coin for e-gift cards

This content was issued through the press release distribution service at Newswire.com.

Attachment

Annual Changes to the Nasdaq Biotechnology Index

NEW YORK, Dec. 10, 2021 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 20, 2021.

The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).

The following 129 securities will be added to the Index:

Exchange Ticker Company
Nasdaq BTX Brooklyn ImmunoTherapeutics, Inc.
Nasdaq LXRX Lexicon Pharmaceuticals, Inc.
Nasdaq CRIS Curis, Inc.
Nasdaq HBIO Harvard Bioscience, Inc.
Nasdaq EYPT EyePoint Pharmaceuticals, Inc.
Nasdaq MTEM Molecular Templates, Inc.
Nasdaq VIRX Viracta Therapeutics, Inc.
Nasdaq AVXL Anavex Life Sciences Corp.
Nasdaq INFI Infinity Pharmaceuticals, Inc.
Nasdaq HROW Harrow Health, Inc.
Nasdaq TNXP Tonix Pharmaceuticals Holding Corp.
Nasdaq CMRX Chimerix, Inc.
Nasdaq ADMA ADMA Biologics Inc
Nasdaq SESN Sesen Bio, Inc.
Nasdaq CLSD Clearside Biomedical, Inc.
Nasdaq PRQR ProQR Therapeutics N.V.
Nasdaq ALPN Alpine Immune Sciences, Inc.
Nasdaq ACRS Aclaris Therapeutics, Inc.
Nasdaq NVCR NovoCure Limited
Nasdaq MRUS Merus N.V.
Nasdaq OCX Oncocyte Corporation
Nasdaq CRVS Corvus Pharmaceuticals, Inc.
Nasdaq LPTX Leap Therapeutics, Inc.
Nasdaq OBSV ObsEva SA
Nasdaq MBIO Mustang Bio, Inc.
Nasdaq OPTN OptiNose, Inc.
Nasdaq SLDB Solid Biosciences Inc.
Nasdaq NRXP NRX Pharmaceuticals, Inc.
Nasdaq EOLS Evolus, Inc.
Nasdaq COGT Cogent Biosciences, Inc.
Nasdaq MREO Mereo BioPharma Group plc
Nasdaq AQST Aquestive Therapeutics, Inc.
Nasdaq EVLO Evelo Biosciences, Inc.
Nasdaq VRCA Verrica Pharmaceuticals Inc.
Nasdaq GRTS Gritstone bio, Inc.
Nasdaq INBX Inhibrx, Inc.
Nasdaq BCYC Bicycle Therapeutics plc
Nasdaq CDAK Codiak BioSciences, Inc.
Nasdaq MIRM Mirum Pharmaceuticals, Inc.
Nasdaq IMPL Impel NeuroPharma, Inc.
Nasdaq MORF Morphic Holding, Inc.
Nasdaq OYST Oyster Point Pharma, Inc.
Nasdaq ETNB 89bio, Inc.
Nasdaq PHAT Phathom Pharmaceuticals, Inc.
Nasdaq FDMT 4D Molecular Therapeutics, Inc.
Nasdaq CVAC CureVac N.V.
Nasdaq HRMY Harmony Biosciences Holdings, Inc.
Nasdaq VTRS Viatris Inc.
Nasdaq QSI Quantum-Si Incorporated
Nasdaq PMVP PMV Pharmaceuticals, Inc.
Nasdaq KYMR Kymera Therapeutics, Inc.
Nasdaq NAUT Nautilus Biotechnology, Inc.
Nasdaq DYN Dyne Therapeutics, Inc.
Nasdaq CCCC C4 Therapeutics, Inc.
Nasdaq HUMA Humacyte, Inc.
Nasdaq ATHA Athira Pharma, Inc.
Nasdaq LABP Landos Biopharma, Inc.
Nasdaq TSHA Taysha Gene Therapies, Inc.
Nasdaq ONCR Oncorus, Inc.
Nasdaq PRAX Praxis Precision Medicines, Inc.
Nasdaq CMPS COMPASS Pathways Plc
Nasdaq PRLD Prelude Therapeutics Incorporated
Nasdaq BOLT Bolt Biotherapeutics, Inc.
Nasdaq ABCM Abcam plc
Nasdaq STTK Shattuck Labs, Inc.
Nasdaq KRON Kronos Bio, Inc.
Nasdaq ALGS Aligos Therapeutics, Inc.
Nasdaq AVIR Atea Pharmaceuticals, Inc.
Nasdaq OLMA Olema Pharmaceuticals, Inc.
Nasdaq SBTX Silverback Therapeutics, Inc.
Nasdaq MRVI Maravai LifeSciences Holdings, Inc.
Nasdaq BCAB BioAtla, Inc.
Nasdaq GRCL Gracell Biotechnologies Inc.
Nasdaq KNTE Kinnate Biopharma Inc.
Nasdaq SEER Seer, Inc.
Nasdaq ME 23andMe Holding Co.
Nasdaq KMPH KemPharm, Inc.
Nasdaq BVS Bioventus Inc.
Nasdaq SNSE Sensei Biotherapeutics, Inc.
Nasdaq SABS SAB Biotherapeutics, Inc.
Nasdaq VOR Vor Biopharma Inc.
Nasdaq ABCL AbCellera Biologics Inc.
Nasdaq CGEM Cullinan Oncology, Inc.
Nasdaq DBTX Decibel Therapeutics, Inc.
Nasdaq CNTB Connect Biopharma Holdings Limited
Nasdaq SANA Sana Biotechnology, Inc.
Nasdaq ACHL Achilles Therapeutics plc
Nasdaq IKNA Ikena Oncology, Inc.
Nasdaq TERN Terns Pharmaceuticals, Inc.
Nasdaq EWTX Edgewise Therapeutics, Inc.
Nasdaq RXRX Recursion Pharmaceuticals, Inc.
Nasdaq RXDX Prometheus Biosciences, Inc.
Nasdaq TIL Instil Bio, Inc.
Nasdaq DSGN Design Therapeutics, Inc.
Nasdaq BMEA Biomea Fusion, Inc.
Nasdaq RAIN Rain Therapeutics Inc.
Nasdaq ATAI ATAI Life Sciences N.V.
Nasdaq CADL Candel Therapeutics, Inc.
Nasdaq HOWL Werewolf Therapeutics, Inc.
Nasdaq TALS Talaris Therapeutics, Inc.
Nasdaq CYT Cyteir Therapeutics, Inc.
Nasdaq OMIC Singular Genomics Systems, Inc.
Nasdaq DNAY Codex DNA, Inc.
Nasdaq CNTA Centessa Pharmaceuticals plc
Nasdaq IMGO Imago BioSciences, Inc.
Nasdaq IPSC Century Therapeutics, Inc.
Nasdaq SERA Sera Prognostics, Inc.
Nasdaq RANI Rani Therapeutics Holdings, Inc.
Nasdaq VERV Verve Therapeutics, Inc.
Nasdaq DAWN Day One Biopharmaceuticals, Inc.
Nasdaq JANX Janux Therapeutics, Inc.
Nasdaq TKNO Alpha Teknova, Inc.
Nasdaq GLUE Monte Rosa Therapeutics, Inc.
Nasdaq RPID Rapid Micro Biosystems, Inc.
Nasdaq AVTE Aerovate Therapeutics, Inc.
Nasdaq ERAS Erasca, Inc.
Nasdaq TNYA Tenaya Therapeutics, Inc.
Nasdaq ICVX Icosavax, Inc.
Nasdaq IMRX Immuneering Corporation
Nasdaq RLYB Rallybio Corporation
Nasdaq GRPH Graphite Bio, Inc.
Nasdaq ABOS Acumen Pharmaceuticals, Inc.
Nasdaq LYEL Lyell Immunopharma, Inc.
Nasdaq ABSI Absci Corporation
Nasdaq NUVL Nuvalent, Inc.
Nasdaq OMGA Omega Therapeutics, Inc.
Nasdaq CRBU Caribou Biosciences, Inc.
Nasdaq MXCT MaxCyte, Inc.
Nasdaq BLU BELLUS Health Inc.

As a result of the reconstitution, the following 21 securities will be removed from the Index:

Exchange Ticker Company
Nasdaq MNOV MediciNova, Inc.
Nasdaq ASMB Assembly Biosciences, Inc.
Nasdaq CNCE Concert Pharmaceuticals, Inc.
Nasdaq ARDX Ardelyx, Inc.
Nasdaq CALA Calithera Biosciences, Inc.
Nasdaq XBIT XBiotech Inc.
Nasdaq KALA Kala Pharmaceuticals, Inc.
Nasdaq VYGR Voyager Therapeutics, Inc.
Nasdaq ODT Odonate Therapeutics, Inc.
Nasdaq VYNE VYNE Therapeutics Inc.
Nasdaq UBX Unity Biotechnology, Inc.
Nasdaq OSMT Osmotica Pharmaceuticals plc
Nasdaq ORTX Orchard Therapeutics plc
Nasdaq KLDO Kaleido Biosciences, Inc.
Nasdaq BCEL Atreca, Inc.
Nasdaq APRE Aprea Therapeutics, Inc.
Nasdaq FUSN Fusion Pharmaceuticals Inc.
Nasdaq INZY Inozyme Pharma, Inc.
Nasdaq TSVTV 2seventy bio, Inc.
Nasdaq ANIP ANI Pharmaceuticals, Inc.
Nasdaq DRNA Dicerna Pharmaceuticals, Inc.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software, and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

Media Contact
Emily Pan
emily.pan@nasdaq.com
+1 (646) 637-3964

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

– NDAQG –

Annual Changes to the Nasdaq-100 Index®

NEW YORK, Dec. 10, 2021 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 20, 2021.

The following six companies will be added to the Index: Airbnb, Inc. (Nasdaq: ABNB), Fortinet, Inc. (Nasdaq: FTNT), Palo Alto Networks, Inc. (Nasdaq: PANW), Lucid Group, Inc. (Nasdaq: LCID), Zscaler, Inc. (Nasdaq: ZS), Datadog, Inc. (Nasdaq: DDOG).

The Nasdaq-100 Index® is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market and dates to January 1985 when it was launched along with the Nasdaq Financial-100 Index, which is comprised of the 100 largest financial stocks on Nasdaq. These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100 Index® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (Nasdaq: QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

As a result of the reconstitution, the following six companies will be removed from the Index: CDW Corporation (Nasdaq: CDW), Fox Corporation (Nasdaq: FOXA/FOX), Cerner Corporation (Nasdaq: CERN), Check Point Software Technologies Ltd. (Nasdaq: CHKP), Trip.com Group Limited (Nasdaq: TCOM), Incyte Corporation (Nasdaq: INCY).

Information

For information about the six companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software, and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

Media Contact
Emily Pan
emily.pan@nasdaq.com
+1 (646) 637-3964

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

– NDAQG –

60% of Japan firms abroad expect to log profits in 2021: poll

Published by
Kyodo News

More than 60 percent of overseas affiliates of Japanese companies expect to post operating profits in 2021, rebounding from a record low of 48.0 percent the previous year but still the second-lowest level in the last decade, according to a survey. The reading of 62.6 percent suggests performances by Japanese businesses operating abroad — which slumped significantly in 2020 due to the impact of the novel coronavirus — “have shown an upswing globally, but the momentum of the recovery lacked strength,” said an online survey by the Japan External Trade Organization. By region, 57.1 percent of Ja… Continue reading “60% of Japan firms abroad expect to log profits in 2021: poll”

Covid-19: Latest global developments

Covid deaths hit four-month high in Peru: Peru, the country with the highest Covid-19 death rate in the world,

records more than 100 deaths on Friday, a figure not seen for four months.

The country begins requiring vaccine certificates in stores, banks and airports due to the increase in cases and deaths. It also bans social gatherings including ones in family homes over Christmas and New Year.

– Denmark sees Omicron surge: Denmark sees 1,840 confirmed cases of the Omicron variant, health

authorities say on Saturday, up by 44 percent from Friday. Earlier in the day, the Epidemic Commission raises the risk level for the spread of the infection to four, on a scale of five, indicating there is a “potential for a high disease burden”.

– Mauritius sees first Omicron cases: The Indian Ocean island nation of Mauritius records its first two infections of the Covid-19 Omicron variant, both linked to people returned from South Africa, with a dozen more contact cases feared.

Health Minister Kailesh Jagutpal tells a news conference the pair were asymptomatic and had tested negative the day before.

– France approves antibody therapy for high-risk cases: French health authorities approve the use of an anti-body treatment made by AstraZeneca for high-risk people who show resistance to vaccines against coronavirus.

Evusheld, developed by the British-Swedish pharma company, this week received emergency use authorisation in the United States for adults and children aged 12 and above.

– Thousands protest compulsory jabs in Austria: Tens of thousands gather in Austria’s capital Vienna to protest mandatory Covid vaccines and home confinement orders for those who have not yet received the jabs.

Police say an estimated 44,000 people attended the demonstration, the latest in a string of huge weekend protests since Austria last month became the first EU country to say it would make Covid vaccinations compulsory.

– Nearly 5.3 million dead:The coronavirus has killed at least 5.29 million people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled on Saturday.

The United States has suffered the most Covid-related deaths with 796,765, followed by Brazil with 616,691, India with 475,128, Mexico with 296,385 and Russia with 288,351.

Taking into account excess mortality linked to Covid-19, the World Health Organization estimates the overall death toll could be two to three times higher.

Source: Nam News Network

Indonesia adds 198 COVID-19 cases in one day

Jakarta Indonesia added 192 positive COVID-19 cases in the 24 hours ended Friday afternoon, with 311 patients recovering from the infection, according to the COVID-19 Response Task Force.

Meanwhile, 5 patients succumbed to the virus, taking the total death toll to 143,923 since the country reported the first confirmed case in March 2020.

According to the task force, the total number of positive COVID-19 cases rose to 4,258,752 and the number of recoveries reached 4,109,675 as of Friday.

The number of active cases or patients undergoing treatment or conducting self-isolation fell by 124 to 5,154, it informed.

Source: Antara News

Cases Of Omicron Variant Rise To 55 In Israel

JERUSALEM, Israel yesterday reported 20 new cases of the Omicron COVID-19 variant, raising the total Omicron cases in the regime to 55, according to the Israeli Health Ministry.

The ministry said that, 36 of the infected are returning passengers from South Africa, Britain, France, the United States, the United Arab Emirates, Belarus, Hungary, Italy and Namibia.

It added that, 11 others were infected in Israel, through close contact with passengers returning from South Africa and Britain, while the remaining eight were infected in Israel, without being abroad nor in close contact with a returning traveller.

In addition, 13 of the 55 infected are unvaccinated, or recovered more than half a year ago.

The ministry also reported another 51 cases, with a high suspicion of infection with Omicron, but the results of their genomic sequencing tests have yet to be obtained.

Source: Nam News Network

US, Japan Agree to Bolster Security Alliance on Sidelines of G-7

LIVERPOOL, ENGLAND — U.S. Secretary of State Antony Blinken agreed Saturday to bolster ties with Japan amid a changing security landscape in the Indo-Pacific region while meeting with Japanese Foreign Minister Yoshimasa Hayashi on the sidelines of the G-7 ministerial in Liverpool.

According to news reports, the top U.S. diplomat and his Japanese counterpart discussed mutual efforts to enhance deterrence and military strike capabilities in the face of China’s military buildup and North Korea’s nuclear program.

“The ministers, in light of the increasingly severe security environment in the region, agreed it is indispensable to boost the deterrence and response capabilities of the Japan-U.S. alliance,” said an official who briefed media after the closed-door meeting.

Japanese Prime Minister Fumio Kishida on Monday unveiled plans to strengthen Tokyo’s military defense posture.

The official said Hayashi and Blinken did not discuss the diplomatic boycott of the Beijing Winter Olympics over China’s human rights record, a move recently endorsed by Canada, Australia, Britain and the United States.

Blinken also met briefly with Australian Foreign Minister Marise Payne on the sidelines of Saturday’s meetings, after which touted a “terrific year” for bilateral ties between the longtime allies without taking questions from reporters.

“Really, really remarkable things between Australia and the United States, from the Quad Leaders’ Summit, to AUKUS, to our 2+2, to the extremely important concentration and coordination on a whole series of issues,” Blinken said.

AUKUS is an acronym for a trilateral alliance between Australia, Britain and the United States, which includes a deal to build nuclear-propelled submarines for Australia—not a G-7 member—as part of enhanced deterrence against China’s military expansion across the Indo-Pacific region.

“I know that you and I [and] our friends from Japan and India really value those engagements,” Payne said. “They are now cemented into our future, whether it is the Quad, whether it is AUKUS. And the concrete that is the Australia-U.S. alliance for us underpins all of that effort.”

Talks amid rising tensions with China, Russia, Iran

Saturday’s meetings come on the first of two days of talks among foreign ministers from the world’s leading industrialized nations, informally known as the G-7, to discuss Russia’s buildup of troops along the border it shares with Ukraine, containing Iran’s nuclear ambitions, addressing the military seizure of Myanmar, and the global coronavirus pandemic.

Talks opened early Saturday with a call from British Foreign Secretary Liz Truss to unite against authoritarianism globally.

“We need to come together strongly to stand up to aggressors who are seeking to limit the bounds of freedom and democracy,” Truss said before meeting with Blinken and their counterparts from France and Germany to discuss ongoing Iran nuclear negotiations unfolding concurrently in Vienna.

Blinken on Friday held “productive” meetings with counterparts from Britain, Germany and France about finding a way forward for the Iran talks, according to a State Department readout.

ASEAN involvement

Blinken also had a series of in-person meetings Saturday with foreign ministers from the Association of Southeast Asian Nations (ASEAN) as part of a Dec. 9-17 trip that also will take him to Indonesia, Malaysia, Thailand and Hawaii.

Blinken’s trip is part of a U.S. effort to further advance its “strategic partnership” with ASEAN as President Joe Biden’s administration aims to begin a new “Indo-Pacific economic framework” in early 2022.

This marks the first time ASEAN countries were included in the G-7 foreign and development ministers’ meeting, wherein the diplomats are discussing China’s efforts to increase its influence in the Indo-Pacific region.

Next week in Jakarta, Indonesia, Blinken will deliver remarks on the significance of the Indo-Pacific region and underscore the importance of the U.S.-Indonesia Strategic Partnership.

“The secretary will have an opportunity to discuss the president’s newly announced Indo-Pacific economic framework,” Daniel Kritenbrink, the State Department’s assistant secretary for East Asian and Pacific Affairs, told reporters in a call briefing. “President Biden is committed to elevating U.S.-ASEAN engagement to unprecedented levels,” he added.

Indonesia is the world’s most populous Muslim majority nation. Kritenbrink told VOA on Wednesday that Blinken will attend a vaccine clinic hosted by the largest faith-based nongovernmental organization in Indonesia.

Blinken then heads to Malaysia and Thailand, where he will attempt to advance U.S. ties and address shared challenges, including fighting COVID-19, building resilient supply chains, dealing with the climate crisis, and ensuring a free and open Indo-Pacific region.

The State Department said Blinken will “address the worsening crisis” in Myanmar in each country during his lengthy trip. The military in Myanmar, formerly known as Burma, seized power in a February coup, overthrowing the civilian government.

U.S. officials had indicated the new Indo-Pacific economic framework would include broad partnerships with nations in the region in critical areas such as the digital economy and technology, supply chain resiliency, and clean energy.

“The Indo-Pacific region is a critical part of our economy. It’s not just that it accounts for over half of the world’s population and 60% of global GDP” (gross domestic product), Jose Fernandez, undersecretary of state for economic growth, energy and the environment, said in a recent briefing.

“Seven of the top 15 U.S. export markets are in the Indo-Pacific. Two-way trade between the U.S. and the region was over $1.75 trillion,” he added.

There are, however, concerns that the U.S. is lagging behind China in deepening economic and strategic ties with ASEAN.

“ASEAN countries want more from Washington on the economic side, but the Biden administration’s proposed Indo-Pacific economic framework is likely to fall short of their expectations,” said Susannah Patton, a research fellow in the foreign policy and defense program at the United States Studies Center in Sydney.

“After RCEP enters into force, there will be two megatrade pacts in Asia: RCEP and CPTPP, and the United States is in neither,” said Patton, referring to the Regional Comprehensive Economic Partnership and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership.

“China’s application to join CPTPP, a vehicle that was designed to promote U.S. economic ties with Asia, highlights Washington’s absence,” Patton told VOA. Signed in 2018, the CPTPP is a free-trade agreement between Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, Peru, New Zealand, Singapore and Vietnam.

In November 2020, 10 ASEAN member states and five additional countries (Australia, China, Japan, South Korea and New Zealand) signed the RCEP, representing around 30% of the world’s GDP and population. RCEP will come into force in January.

Others said the new Indo-Pacific economic framework appears to be not just about traditional trade, as Washington is signaling strategic interests in the region.

Source: Voice of America